Patents by Inventor Gabriel Iobbi
Gabriel Iobbi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12042467Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cirType: GrantFiled: April 15, 2022Date of Patent: July 23, 2024Assignee: Novartis AGInventors: Andrew Bryant, Alain Schmidlin, Daniel Latham, Gabriel Iobbi, Arun Venkatasubramanian, Thomas Richard Redman, Timothy Duncan Wooller, Franck Rubiconi, Robert George Milner, Richard Andrew Hall, Symon Cotton, Simon Peter Attard
-
Publication number: 20220257468Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cirType: ApplicationFiled: April 15, 2022Publication date: August 18, 2022Inventors: Andrew BRYANT, Alain Schmidlin, Daniel Latham, Gabriel Iobbi, Arun Venkatasubramanian, Thomas Richard Redman, Timothy Duncan Wooller, Franck Rubiconi, Robert George Milner, Richard Andrew Hall, Symon Cotton, Simon Peter Attard
-
Patent number: 11324661Abstract: A pharmaceutical container includes a cylindrical hollow container body defining a hollow chamber to receive a pharmaceutical liquid, the container body including a portion on a sidewall) of the container body, wherein the portion has a longitudinal extension along the longitudinal axis of the container body and a circumferential extension along the circumference of the container body, thereby forming a window through the sidewall of the container body into the hollow chamber. In embodiments of the invention, the window comprises two long edges and two short edges, and a Near Field Communication (NFC) antenna. In embodiments of the invention, the antenna comprises one or a plurality of nested antenna windings.Type: GrantFiled: February 17, 2017Date of Patent: May 10, 2022Assignee: Novartis AGInventors: Andrew Bryant, Alain Schmidlin, Daniel Latham, Gabriel Iobbi, Arun Venkatasubramanian, Thomas Richard Redman, Timothy Duncan Wooller, Franck Rubiconi, Robert George Milner, Richard Andrew Hall, Symon Cotton, Simon Peter Attard
-
Patent number: 10624739Abstract: An assembly for treating a native valve in a human heart includes a prosthetic heart valve having an expandable frame and a valvular structure. The assembly also includes a tubular sleeve and a valve catheter disposed within the sleeve. A plurality of metal extension arms are coupled to the valve catheter for holding the prosthetic heart valve. The extension arms are configured to radially expand with the prosthetic heart valve during expansion of the prosthetic heart valve at a treatment site. A plurality of metal rods extend distally from the valve catheter. The rods are axially movable relative to the extension arms. A plurality of release members are provided for releasing the prosthetic heart valve from the extension arms upon movement of the metal rods.Type: GrantFiled: December 6, 2017Date of Patent: April 21, 2020Assignee: Edwards Lifesciences CorporationInventors: Henry Bourang, Thanh Huy Le, David M. Taylor, Sam Sok, Mario M. Gabriel Iobbi, David J. Evans, Rajesh A. Khanna
-
Publication number: 20190038507Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cirType: ApplicationFiled: February 17, 2017Publication date: February 7, 2019Inventors: Andrew Bryant, Alain Schmidlin, Daniel Latham, Gabriel Iobbi, Arun Venkatasubramanian, Thomas Richard Redman, Timothy Duncan Wooller, Franck Rubiconi, Robert George Milner, Richard Andrew Hall, Symon Cotton, Simon Peter Attard
-
Patent number: 10159567Abstract: A prosthetic heart valve has three cusp regions positioned at an inflow end intermediate three commissure regions positioned at an outflow end thereof. A support frame including three cusp positioners is fixed with respect to a leaflet frame and located intermediate each pair of adjacent commissure regions. The valve is desirably compressible. In the aortic valve position, the cusp positioners angle outward into contact with the sinus cavities, and compress the native leaflets if they are not excised, or the aortic wall if they are.Type: GrantFiled: August 7, 2017Date of Patent: December 25, 2018Assignee: Edwards Lifesciences CorporationInventor: Mario M Gabriel Iobbi
-
Publication number: 20180125643Abstract: An assembly for treating a native valve in a human heart includes a prosthetic heart valve having an expandable frame and a valvular structure. The assembly also includes a tubular sleeve and a valve catheter disposed within the sleeve. A plurality of metal extension arms are coupled to the valve catheter for holding the prosthetic heart valve. The extension arms are configured to radially expand with the prosthetic heart valve during expansion of the prosthetic heart valve at a treatment site. A plurality of metal rods extend distally from the valve catheter. The rods are axially movable relative to the extension arms. A plurality of release members are provided for releasing the prosthetic heart valve from the extension arms upon movement of the metal rods.Type: ApplicationFiled: December 6, 2017Publication date: May 10, 2018Applicant: Edwards Lifesciences CorporationInventors: Henry Bourang, Thanh Huy Le, David M. Taylor, Sam Sok, Mario M. Gabriel Iobbi, David J. Evans, Rajesh A. Khanna
-
Patent number: 9839514Abstract: An assembly for treating a native heart valve can include a prosthetic valve and a delivery apparatus. The prosthetic valve can include an expandable frame, a valve structure, a first end with apertures formed therein, and a second end. The delivery apparatus can include a valve catheter, flexible extension arms, slidable wires, and release members. First ends of the arms can be coupled to a cylindrical coupling element, second ends of the arms can be releasably coupled to the prosthetic valve, and the coupling element can be connected to the distal end of the valve catheter. The slidable wires can extend distally from the distal end of the valve catheter. The release members can be coupled to the distal end of the valve catheter and can extend through a respective aperture of the prosthetic valve, thereby forming a releasable connection between the prosthetic valve and the slidable wires.Type: GrantFiled: November 9, 2016Date of Patent: December 12, 2017Assignee: Edwards Lifesciences CorporationInventors: Henry Bourang, Thanh Huy Le, David M. Taylor, Sam Sok, Mario Gabriel Iobbi, David J. Evans, Rajesh A. Khanna
-
Publication number: 20170333182Abstract: A prosthetic heart valve has three cusp regions positioned at an inflow end intermediate three commissure regions positioned at an outflow end thereof. A support frame including three cusp positioners is fixed with respect to a leaflet frame and located intermediate each pair of adjacent commissure regions. The valve is desirably compressible. In the aortic valve position, the cusp positioners angle outward into contact with the sinus cavities, and compress the native leaflets if they are not excised, or the aortic wall if they are.Type: ApplicationFiled: August 7, 2017Publication date: November 23, 2017Inventor: Mario M. Gabriel Iobbi
-
Patent number: 9724193Abstract: A prosthetic heart valve includes three bioprosthetic leaflets, each having an arcuate outer edge opposite a coapting edge and two tabs located on opposite sides of the coapting edge. The prosthetic heart valve also includes a self-expandable support frame defining three commissures spaced 120 degrees apart. Each commissure preferably includes two axially-extending attachment flanges with an axial slot therebetween. Each attachment flange includes a plurality of assembly holes through which sutures are passed to secure the leaflet tabs to the attachment flanges. The prosthetic heart valve also includes three outwardly flared U-shaped stabilizing members integrally formed with the leaflet support frame. The three stabilizing members having outer apices spaced 120 degrees apart and offset by 60 degrees from the three commissures. The stabilizing members are shaped to contact the surrounding aorta for stabilizing and anchoring the prosthetic heart valve in the implant position.Type: GrantFiled: April 25, 2016Date of Patent: August 8, 2017Assignee: Edwards Lifesciences CorporationInventor: Mario M Gabriel Iobbi
-
Publication number: 20170056161Abstract: An assembly for treating a native heart valve can include a prosthetic valve and a delivery apparatus. The prosthetic valve can include an expandable frame, a valve structure, a first end with apertures formed therein, and a second end. The delivery apparatus can include a valve catheter, flexible extension arms, slidable wires, and release members. First ends of the arms can be coupled to a cylindrical coupling element, second ends of the arms can be releasably coupled to the prosthetic valve, and the coupling element can be connected to the distal end of the valve catheter. The slidable wires can extend distally from the distal end of the valve catheter. The release members can be coupled to the distal end of the valve catheter and can extend through a respective aperture of the prosthetic valve, thereby forming a releasable connection between the prosthetic valve and the slidable wires.Type: ApplicationFiled: November 9, 2016Publication date: March 2, 2017Applicant: Edwards Lifesciences CorporationInventors: Henry Bourang, Thanh Huy Le, David M. Taylor, Sam Sok, Mario Gabriel Iobbi, David J. Evans, Rajesh A. Khanna
-
Patent number: D833003Type: GrantFiled: October 1, 2015Date of Patent: November 6, 2018Assignee: NOVARTIS AGInventors: Wolfgang Papst, Daniel Latham, Gabriel Iobbi, Andrew Bryant
-
Patent number: D839411Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D839412Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D839413Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D839414Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D839415Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D839416Type: GrantFiled: June 14, 2017Date of Patent: January 29, 2019Assignee: Novartis AGInventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
-
Patent number: D959694Type: GrantFiled: October 1, 2015Date of Patent: August 2, 2022Assignee: NOVARTIS AGInventors: Wolfgang Papst, Daniel Latham, Gabriel Iobbi, Andrew Bryant
-
Patent number: D959695Type: GrantFiled: October 1, 2015Date of Patent: August 2, 2022Assignee: NOVARTIS AGInventors: Wolfgang Papst, Daniel Latham, Gabriel Iobbi, Andrew Bryant